Transcript segment

Baric Transcribed Interview (Redacted), pp.107-108 · baric_ti:utt:00921

Date: 2026-04-10 09:00 (day precision)
Type: transcript segment · interview
recipient: Christina Salazar, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker: Ralph S. Baric
Topics: Vaccines

Yeah. I think you have to think about where the focus of the research community was. My focuses, at the time, were to rapidly develop mouse models so that we could test mRNA-LNP-based vaccines against SARS-2, to work with Gilead to get their drug forward into clinical trials, to get molnupiravir, a second drug that was FDA approved for use in humans, into clinical trials. DC.Scheduling@LexitasLegal.com

Extracted statements

Rule-extracted, not adjudicated. The grade says what may be done with each one; read the document above before relying on any of them.

Statement	Grade	Attribution	Stance
My focuses, at the time, were to rapidly develop mouse models so that we could test mRNA-LNP-based vaccines against SARS-2, to work with Gilead to get their drug forward into clinical trials, to get molnupiravir, a second drug that was FDA approved for use in humans, into clinical trials.	own voice, substantive	speaker_own	asserts

Statement

Grade

Attribution

Stance

My focuses, at the time, were to rapidly develop mouse models so that we could test mRNA-LNP-based vaccines against SARS-2, to work with Gilead to get their drug forward into clinical trials, to get molnupiravir, a second drug that was FDA approved for use in humans, into clinical trials.

own voice, substantive

speaker_own

asserts

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

2026-04-10 09:00 Ralph S. Baric open

Yes, he would have been there.
2026-04-10 09:00 Christina Salazar open

But he never raised it. To me it's odd that you wouldn't recall that.
2026-04-10 09:00 Ralph S. Baric open

If he would've raised it, I would've remembered it then, because he would've put it in context.
2026-04-10 09:00 Christina Salazar open

And he would've told you, right.
2026-04-10 09:00 Ralph S. Baric

Yeah. I think you have to think about where the focus of the research community was. My focuses, at the time, were to rapidly develop mouse models so that we could test mRNA-LNP-based vaccines against SARS-2, to work with Gilead to get their drug forward into clinical trials, to get molnupiravir, a second drug that was FDA approved for use in humans, into clinical trials. DC.Scheduling@LexitasLegal.com
2026-04-10 09:00 Christina Salazar open

But, you know, part of the conversation --
2026-04-10 09:00 Ralph S. Baric open

Yeah, hindsight is always 20/20 in this case. So you can look at a document and say why can't I remember.
2026-04-10 09:00 Christina Salazar open

No. I mean, I think part of the conversation, though, for a long time, was, I mean, the debate over whether it was a natural original, a lab leak, you know, accidental or not. I mean, this was a conversation that was happening in the public. There were multiple papers authored. We had Proximal Origins. People were shamed and called conspiracy theorists. I mean, is that not true?
2026-04-10 09:00 Ralph S. Baric open

That's true.

Full conversation →